1. Home
  2. OLMA vs BYON Comparison

OLMA vs BYON Comparison

Compare OLMA & BYON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OLMA
  • BYON
  • Stock Information
  • Founded
  • OLMA 2006
  • BYON 1997
  • Country
  • OLMA United States
  • BYON United States
  • Employees
  • OLMA N/A
  • BYON N/A
  • Industry
  • OLMA Biotechnology: Pharmaceutical Preparations
  • BYON Catalog/Specialty Distribution
  • Sector
  • OLMA Health Care
  • BYON Consumer Discretionary
  • Exchange
  • OLMA Nasdaq
  • BYON Nasdaq
  • Market Cap
  • OLMA 525.7M
  • BYON 450.6M
  • IPO Year
  • OLMA 2020
  • BYON N/A
  • Fundamental
  • Price
  • OLMA $9.43
  • BYON $6.09
  • Analyst Decision
  • OLMA Strong Buy
  • BYON Buy
  • Analyst Count
  • OLMA 5
  • BYON 9
  • Target Price
  • OLMA $27.00
  • BYON $17.13
  • AVG Volume (30 Days)
  • OLMA 417.7K
  • BYON 3.5M
  • Earning Date
  • OLMA 11-12-2024
  • BYON 10-24-2024
  • Dividend Yield
  • OLMA N/A
  • BYON N/A
  • EPS Growth
  • OLMA N/A
  • BYON N/A
  • EPS
  • OLMA N/A
  • BYON N/A
  • Revenue
  • OLMA N/A
  • BYON $1,476,271,000.00
  • Revenue This Year
  • OLMA N/A
  • BYON N/A
  • Revenue Next Year
  • OLMA N/A
  • BYON $3.58
  • P/E Ratio
  • OLMA N/A
  • BYON N/A
  • Revenue Growth
  • OLMA N/A
  • BYON N/A
  • 52 Week Low
  • OLMA $8.51
  • BYON $5.96
  • 52 Week High
  • OLMA $17.10
  • BYON $37.10
  • Technical
  • Relative Strength Index (RSI)
  • OLMA 28.00
  • BYON 29.39
  • Support Level
  • OLMA $11.46
  • BYON $5.96
  • Resistance Level
  • OLMA $13.06
  • BYON $6.70
  • Average True Range (ATR)
  • OLMA 0.80
  • BYON 0.37
  • MACD
  • OLMA -0.23
  • BYON 0.05
  • Stochastic Oscillator
  • OLMA 0.00
  • BYON 10.57

About OLMA Olema Pharmaceuticals Inc.

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

About BYON Beyond Inc.

Beyond Inc is an online retailer that provides products and services through websites. The company offers a broad range of products, including furniture, décor, area rugs, bedding and bath, home improvement, outdoor, and kitchen and dining items, BMMG (like books, magazines, CDs), electronics, and other items. The home and garden product line accounts for a material part of its total revenue. The company operates through a direct business that makes sales from the company's own inventory, and a partner business that sells merchandise from manufacturers, distributors, and other suppliers through the company's websites. The company generates the majority of its total revenue from partner business in terms of business format, and from the U.S. in terms of market.

Share on Social Networks: